cocircul
distinct
influenza
type
subtyp
strain
allow
rare
coincident
infect
one
type
subtyp
addit
consecut
infect
influenza
b
virus
within
singl
season
recurr
influenza
infect
also
report
two
immunocompet
report
uniqu
case
two
sequenti
infect
highli
similar
influenza
virus
usual
healthi
vaccin
child
case
identifi
within
research
studi
occur
outsid
medic
care
set
briefli
sinc
januari
longitudin
influenza
surveil
studi
ongo
oregon
school
district
osd
south
central
wisconsin
orchard
oregon
child
absente
due
respiratori
diseas
studi
design
assess
util
school
absente
monitor
earli
influenza
outbreak
detect
compar
absente
medic
attend
influenza
surround
commun
parent
children
ill
ili
symptom
voluntarili
call
studi
hotlin
student
screen
ili
criteria
elig
receiv
home
visit
research
team
member
research
staff
collect
nasal
nasooropharyng
npop
specimen
along
symptom
epidemiolog
data
specimen
test
rapid
influenza
diagnost
test
ridt
quidel
sofia
influenza
b
fia
within
hour
home
visit
specimen
test
influenza
ivd
cdc
human
influenza
viru
diagnost
panel
respiratori
virus
luminex
nxtag
respiratori
pathogen
panel
rpp
wisconsin
state
laboratori
hygien
wslh
wslh
undergo
rigor
valid
process
diagnost
test
includ
accord
feder
clia
licens
standard
unidirect
workflow
prepar
aliquot
one
specimen
time
dedic
specimen
process
equip
laboratori
area
decontamin
biosafeti
cabinet
bsc
laboratori
bench
use
ensur
risk
minim
begin
septemb
famili
orchard
subject
invit
particip
home
transmiss
substudi
nasal
swab
obtain
famili
member
day
visit
day
day
later
along
day
nasal
swab
orchard
subject
specimen
household
member
test
influenza
use
except
case
studi
genom
sequenc
perform
wslh
use
illumina
platform
sequenc
read
trim
use
trimmomat
slide
window
qualiti
score
cutoff
sampl
map
trim
sequenc
read
vaccin
strain
ha
refer
sequenc
ahong
use
geneiou
version
univers
wisconsin
institut
review
board
irb
approv
studi
protocol
center
diseas
control
prevent
human
research
protect
offic
review
approv
deferr
univers
wisconsin
irb
januari
usual
healthi
old
white
femal
screen
orchard
elig
figur
vaccin
quadrival
inactiv
influenza
vaccin
octob
student
live
parent
two
younger
sibl
famili
member
receiv
influenza
vaccin
home
visit
conduct
hour
symptom
onset
moder
ili
character
fever
measur
temperatur
antipyret
chill
cough
sore
throat
rhinorrhea
nasal
congest
headach
malais
myalgia
anorexia
sneez
recent
travel
exposur
farm
anim
identifi
sick
contact
preced
onset
nasal
oropharyng
specimen
collect
although
ridt
result
neg
posit
influenza
cycl
threshold
valu
ct
rpp
posit
coronaviru
report
day
absente
continu
cough
rhinorrhea
sore
throat
myalgia
headach
medic
antivir
treatment
result
subject
day
swab
neg
influenza
famili
member
report
ill
day
one
sibl
develop
mild
respiratori
ill
day
famili
member
test
neg
influenza
day
day
march
day
initi
encount
subject
screen
due
new
ili
episod
home
visit
conduct
hour
symptom
onset
year
old
subject
complain
signific
symptom
includ
fever
measur
temperatur
antipyret
chill
cough
wheez
nasal
congest
headach
malais
myalgia
anorexia
burn
eye
dizzi
recent
travel
exposur
farm
anim
identifi
sick
contact
preced
onset
subject
ridt
result
posit
influenza
result
confirm
presenc
influenza
ct
report
day
absente
continu
fever
chill
cough
rhinorrhea
malais
myalgia
headach
anorexia
medic
antivir
treatment
result
subject
day
swab
continu
show
influenza
ct
famili
member
report
ill
day
day
famili
member
test
neg
influenza
day
day
subject
initi
specimen
episod
collect
januari
march
prepar
full
genom
sequenc
wslh
strain
hemagglutinin
gene
clade
wslh
perform
consensu
sequenc
comparison
two
virus
collect
subject
three
singl
nucleotid
polymorph
snp
identifi
within
code
region
ha
protein
one
snp
result
isoleucin
leucin
chang
posit
particular
polymorph
near
frequenc
sequenc
read
four
amino
acid
away
establish
antibodi
epitop
site
site
e
sequenc
first
isol
second
isol
submit
genet
sequenc
databas
given
access
number
respect
first
known
case
two
sequenti
infect
influenza
moreov
case
occur
within
immunocompet
fulli
vaccin
child
period
ili
episod
day
absenc
influenza
pcr
first
episod
resolut
symptom
develop
new
ili
support
two
distinct
episod
influenza
infect
first
episod
coinfect
coronaviru
document
well
high
ct
valu
influenza
fals
neg
ridt
may
impli
rel
low
viral
load
possibl
immun
interfer
induc
coinfect
although
estim
vaccin
effect
influenza
season
low
ci
season
vaccin
may
offer
partial
second
episod
subject
ili
signific
ridt
posit
initi
specimen
manifest
much
lower
ct
valu
impli
higher
viral
load
occur
despit
vaccin
receipt
prior
infect
influenza
subtyp
time
first
episod
rel
second
neutral
antibodi
although
two
virus
genet
similar
cluster
virus
circul
within
commun
possibl
polymorph
could
impart
structur
chang
affect
antibodi
recognit
case
suggest
influenza
viru
evad
immun
respons
immunocompet
vaccin
child
recent
infect
similar
viru
known
influenza
remain
establish
surveil
system
reli
report
medic
attend
case
demonstr
intrins
valu
longitudin
studi
influenza
within
commun
coupl
laboratori
support
provid
antigen
character
genom
sequenc
focu
medic
attend
influenza
would
miss
case
cocircul
clade
variant
within
singl
commun
caus
reinfect
may
offer
possibl
explan
prolong
intens
influenza
season
experienc
assess
need
assess
frequenc
reinfect
influenza
author
conflict
interest
declar
